Rhumbline Advisers Surmodics Inc Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Surmodics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 20,628 shares of SRDX stock, worth $592,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,628

Previous 20,364 1.3%

Holding current value

$592,229

Previous $621,000 1.45%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$26.76 - $31.1 $7,064 - $8,210	264 Added 1.3%	20,628 $612,000
Q1 2025 Apr 08, 2025	BUY	$26.71 - $39.71 $3,044 - $4,526	114 Added 0.56%	20,364 $626,000
Q4 2024 May 29, 2025	SELL	$37.5 - $40.13 $4,275 - $4,574	-114 Reduced 0.56%	20,250 $801,000
Q4 2024 Jan 30, 2025	BUY	$37.5 - $40.13 $32,287 - $34,551	861 Added 4.44%	20,250 $801,000
Q3 2024 Nov 12, 2024	SELL	$38.47 - $42.24 $61,936 - $68,006	-1,610 Reduced 7.67%	19,389 $751,000
Q2 2024 Aug 01, 2024	BUY	$25.39 - $42.1 $62,535 - $103,692	2,463 Added 13.29%	20,999 $882,000
Q1 2024 May 09, 2024	BUY	$27.44 - $35.56 $19,564 - $25,354	713 Added 4.0%	18,536 $543,000
Q4 2023 Feb 08, 2024	SELL	$28.47 - $38.49 $6,491 - $8,775	-228 Reduced 1.26%	17,823 $647,000
Q3 2023 Nov 09, 2023	SELL	$28.28 - $38.36 $1,979 - $2,685	-70 Reduced 0.39%	18,051 $579,000
Q2 2023 Aug 08, 2023	BUY	$17.67 - $31.31 $3,869 - $6,856	219 Added 1.22%	18,121 $567,000
Q1 2023 May 11, 2023	SELL	$17.13 - $38.52 $365,177 - $821,169	-21,318 Reduced 54.35%	17,902 $408,000
Q4 2022 Feb 14, 2023	BUY	$29.44 - $37.31 $24,641 - $31,228	837 Added 2.18%	39,220 $1.34 Million
Q3 2022 Nov 10, 2022	BUY	$28.84 - $38.92 $35,905 - $48,455	1,245 Added 3.35%	38,383 $1.17 Million
Q2 2022 Aug 11, 2022	BUY	$33.25 - $45.11 $10,374 - $14,074	312 Added 0.85%	37,138 $1.38 Million
Q1 2022 May 12, 2022	BUY	$40.68 - $49.72 $64,315 - $78,607	1,581 Added 4.49%	36,826 $1.67 Million
Q4 2021 Feb 10, 2022	SELL	$43.21 - $57.6 $11,018 - $14,688	-255 Reduced 0.72%	35,245 $1.7 Million
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $290,875 - $332,302	-5,509 Reduced 13.43%	35,500 $1.97 Million
Q2 2021 Aug 05, 2021	SELL	$51.29 - $59.15 $51,443 - $59,327	-1,003 Reduced 2.39%	41,009 $2.23 Million
Q1 2021 May 06, 2021	BUY	$42.18 - $56.07 $29,610 - $39,361	702 Added 1.7%	42,012 $2.36 Million
Q4 2020 Feb 10, 2021	BUY	$35.18 - $43.52 $102,268 - $126,512	2,907 Added 7.57%	41,310 $1.8 Million
Q3 2020 Nov 12, 2020	SELL	$37.98 - $48.72 $62,249 - $79,852	-1,639 Reduced 4.09%	38,403 $1.49 Million
Q2 2020 Aug 13, 2020	SELL	$31.07 - $44.74 $272,452 - $392,325	-8,769 Reduced 17.97%	40,042 $1.73 Million
Q1 2020 May 06, 2020	SELL	$22.46 - $42.24 $138,982 - $261,381	-6,188 Reduced 11.25%	48,811 $1.63 Million
Q4 2019 Feb 05, 2020	BUY	$39.01 - $47.51 $99,397 - $121,055	2,548 Added 4.86%	54,999 $2.28 Million
Q3 2019 Oct 23, 2019	BUY	$38.66 - $47.41 $16,082 - $19,722	416 Added 0.8%	52,451 $2.4 Million
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $406,423 - $504,228	10,631 Added 25.68%	52,035 $2.25 Million
Q1 2019 May 01, 2019	SELL	$41.26 - $58.35 $310,646 - $439,317	-7,529 Reduced 15.39%	41,404 $1.8 Million
Q4 2018 Jan 31, 2019	BUY	$44.93 - $73.38 $746,736 - $1.22 Million	16,620 Added 51.43%	48,933 $2.31 Million
Q3 2018 Nov 07, 2018	SELL	$56.85 - $80.35 $19,499 - $27,560	-343 Reduced 1.05%	32,313 $2.41 Million
Q2 2018 Aug 06, 2018	BUY	$35.85 - $57.05 $29,755 - $47,351	830 Added 2.61%	32,656 $1.8 Million
Q1 2018 May 02, 2018	BUY	$27.0 - $38.5 $17,766 - $25,333	658 Added 2.11%	31,826 $1.21 Million
Q4 2017 Feb 09, 2018	BUY	$28.0 - $33.2 $101,220 - $120,018	3,615 Added 13.12%	31,168 $873,000
Q3 2017 Nov 06, 2017	BUY	$24.5 - $31.1 $675,048 - $856,898	27,553	27,553 $854,000

Others Institutions Holding SRDX

# of Institutions

143

Shares Held

12.3M

Call Options Held

103K

Put Options Held

212K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $402M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Surmodics Inc Transaction History